TSX:PRN - Post Discussion
Post by
homer111 on Nov 04, 2024 5:03pm
PRN-TULSA Reimbursement Raised to Urology APC Level 7...
https://ca.finance.yahoo.com/news/profound-medical-announces-tulsa-reimbursement-115500697.html Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that U.S. Centers for Medicare and Medicaid Services (“CMS”) has released its final rule (the “Final Rule”) establishing, for the first time, a Category 1 CPT® code for the Transurethral Ultrasound Ablation (“TULSA”) procedure, effective January 1, 2025.
Be the first to comment on this post